Keryx Biopharmaceuticals (KERX) Announces Appointment Of Daniel W. Olmstead As Vice President, Payer Access
1/21/2014 9:01:06 AM
NEW YORK, Jan. 21, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease (the "Company"), today announced the appointment of Daniel W. Olmstead to the newly created position of Vice President, Payer Access. In this role, Mr. Olmstead will lead the Company's strategic global market access, managed care and reimbursement initiatives.
Help employers find you! Check out all the jobs and post your resume.
comments powered by